Plasma phentermine levels, weight loss and side-effects.

Author: DouglasA, DouglasJ G, MunroJ F, RobertsonC E

Paper Details 
Original Abstract of the Article :
Fifty women with refractory obesity received phentermine resinate. Seven were withdrawn because of side-effects: three developed severe headaches, one each hypertension, depressive symptoms, breathlessness and palpitations with irritability. The mean weight loss in the 34 who completed the 20-week s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/6654575

データ提供:米国国立医学図書館(NLM)

Phentermine for Refractory Obesity: Unpredictable Response

This research navigates the challenging terrain of refractory obesity, exploring the effectiveness of phentermine resinate as a treatment option. The authors examine the relationship between plasma phentermine levels, weight loss, and side effects in a group of women with refractory obesity. Their findings reveal that while some individuals experience significant weight loss, the response to phentermine is unpredictable, suggesting that factors beyond plasma drug concentration play a role in treatment success.

A Challenging Landscape: The Unpredictability of Phentermine

This research sheds light on the unpredictable nature of phentermine's effectiveness in treating refractory obesity. The authors found that while some individuals experienced substantial weight loss, others did not, highlighting the complex factors influencing treatment response. Think of it like searching for an oasis in the desert – sometimes you find it, and sometimes you don't, depending on the path you take and the conditions you encounter.

Navigating the Desert of Obesity: Seeking Personalized Solutions

As a researcher, I am always searching for effective and personalized solutions for complex health conditions. This research highlights the importance of individualized treatment approaches in managing refractory obesity. The findings emphasize that factors beyond plasma drug concentration influence treatment response, underscoring the need for personalized strategies tailored to individual patient needs.

Dr.Camel's Conclusion

This study explores the use of phentermine resinate for treating refractory obesity. The findings highlight the unpredictable nature of phentermine's effectiveness, emphasizing the need for personalized treatment approaches and further research to understand the complex factors influencing treatment response. It's like navigating a vast and unforgiving desert – finding the right path for each individual is crucial for success.
Date :
  1. Date Completed 1984-02-14
  2. Date Revised 2014-06-03
Further Info :

Pubmed ID

6654575

DOI: Digital Object Identifier

6654575

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.